| Helen Porter Healthcare & Rehab | |
| 30 Porter Drive, Middlebury, Vermont 05753 | |
| (802) 388-4001 | |
| Name | Helen Porter Healthcare & Rehab |
|---|---|
| Location | 30 Porter Drive, Middlebury, Vermont |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 98 |
| Occupancy Rate | 79.59% |
| Medicare ID (CCN) | 475017 |
| Legal Business Name | Helen Porter Nursing Home, Inc. |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1932108222 |
| Organization Name | HELEN PORTER NURSING HOME INC |
| Doing Business As | HELEN PORTER HEALTHCARE & REHABILITATION CENTER |
| Address | 30 Porter Dr, Middlebury, VT 05753 |
| Phone Number | 802-388-4001 |
News Archive
Vical Incorporated today reported financial results for the quarter ended March 31, 2010. Revenues were $1.5 million for the first quarter of 2010 compared with $2.3 million for the first quarter of 2009, reflecting lower revenues under the company's license agreement with AnGes MG, Inc. Operating expenses were $10.1 million for the first quarter of 2010 compared with $10.6 million for the first quarter of 2009.
A new Spanish study has found that a combination of chemotherapy drugs can increase the five-year survival rate of women with metastatic, node-positive breast cancer by 7 percent.
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at The University of Texas at Austin.
MSI Surgical Solutions, an Empire Investment Holdings company, announced today that it has expanded its ETO (Ethylene Oxide) sterilization capabilities through the addition of three new autoclaves. ETO machines are critical in the sterilization of both disposable and reusable items made of rubber or paper products, items that are sensitive to heat or moisture and medical device components including probes, scopes, tubes, cords, wires and leads.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Vical Incorporated today reported financial results for the quarter ended March 31, 2010. Revenues were $1.5 million for the first quarter of 2010 compared with $2.3 million for the first quarter of 2009, reflecting lower revenues under the company's license agreement with AnGes MG, Inc. Operating expenses were $10.1 million for the first quarter of 2010 compared with $10.6 million for the first quarter of 2009.
A new Spanish study has found that a combination of chemotherapy drugs can increase the five-year survival rate of women with metastatic, node-positive breast cancer by 7 percent.
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at The University of Texas at Austin.
MSI Surgical Solutions, an Empire Investment Holdings company, announced today that it has expanded its ETO (Ethylene Oxide) sterilization capabilities through the addition of three new autoclaves. ETO machines are critical in the sterilization of both disposable and reusable items made of rubber or paper products, items that are sensitive to heat or moisture and medical device components including probes, scopes, tubes, cords, wires and leads.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.52 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 2.26 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 61.17 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.19 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.17 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 15.93 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.41 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.12 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 83.82 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.53 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 26.78 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.79 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 8.46 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.59 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 82.75 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 79.51 | 82.93 |
News Archive
Vical Incorporated today reported financial results for the quarter ended March 31, 2010. Revenues were $1.5 million for the first quarter of 2010 compared with $2.3 million for the first quarter of 2009, reflecting lower revenues under the company's license agreement with AnGes MG, Inc. Operating expenses were $10.1 million for the first quarter of 2010 compared with $10.6 million for the first quarter of 2009.
A new Spanish study has found that a combination of chemotherapy drugs can increase the five-year survival rate of women with metastatic, node-positive breast cancer by 7 percent.
For 50 years scientists have been unsure how the bacteria that gives humans cholera manages to resist one of our basic innate immune responses. That mystery has now been solved, thanks to research from biologists at The University of Texas at Austin.
MSI Surgical Solutions, an Empire Investment Holdings company, announced today that it has expanded its ETO (Ethylene Oxide) sterilization capabilities through the addition of three new autoclaves. ETO machines are critical in the sterilization of both disposable and reusable items made of rubber or paper products, items that are sensitive to heat or moisture and medical device components including probes, scopes, tubes, cords, wires and leads.
› Verified 7 days ago
Helen Porter Healthcare & Rehab Location: 30 Porter Drive, Middlebury, Vermont 05753 Phone: (802) 388-4001 |